Therapeutic Apheresis Market Outlook

The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2,717.9 million in 2023 and is expected to reach US$ 5,264.4 million by 2033.

The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.

Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.

Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.

Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX), and cellular depletion. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.

TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Is Driving The Global Therapeutic Apheresis Sector?

  • Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis industry.
  • The growing dominance of various therapeutic procedures such as fluid replacement therapy, red cell exchange, dendritic cells cancer therapy, car T cells therapy, and extracorporeal therapy is broadly stirring the growth rate of the global market.
  • Escalating trauma and injury cases, growing cases of chronic diseases, rising need for blood components and more awareness pertaining to blood safety, favorable reimbursement policies, and a growing number of complicated surgical procedures are all responsible for the lucrative growth of the market.
  • Constantly increasing geriatric population coupled with increasing healthcare expenditure and growing use of therapeutic apheresis in treating cancer is likely to boost the growth of the global therapeutic apheresis sector.
Attributes Value
Therapeutic Apheresis Market Size (2023) US$ 2,717.9 million
Therapeutic Apheresis Market Projected Size (2033) US$ 5,264.4 million
Therapeutic Apheresis Market CAGR (2023 to 2033) 6.8%

Restraining Factors Hampering The Market Growth

  • Therapeutic apheresis procedures, apheresis devices, and installing the apheresis devices are an expensive affair and therefore the high cost associated with these procedures is anticipated to obstruct the growth of the therapeutic apheresis business.
  • Lack of awareness coupled with a dearth of qualified specialists and problems associated with apheresis methods is likely to suppress the global market expansion.
  • Apheresis results in the growing occurrence of several disorders and diseases such as the growth of germ cell tumors from stem cells of the germ line and early embryo, Guillain-Barré syndrome, Paraproteinemia, Waldenstrom's macroglobulinemia, non-Hodgkin’s lymphoma, symptomatic myeloma, and many others are broadly hindering the growth of the market.

Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of the Market

Therapeutic Apheresis Market:

Attributes Therapeutic Apheresis Market
CAGR (2023 to 2033) 6.8%
Market Value (2033) US$ 5,264.4 million
Growth Factor Promotes rapid healing
Opportunity Tech-advancements in treatments
Key Trends High demand for battery operated beds

Compression Therapy Market:

Attributes Compression Therapy Market
CAGR (2023 to 2033) 5.4%
Market Value (2033) US$ 4,840 million
Growth Factor Growing incidence of venous ulcers
Opportunity Development of patient -centric products
Key Trends Applications in promoting mental health

Negative Pressure Wound therapy Market:

Attributes Negative Pressure Wound therapy Market
CAGR (2023 to 2033) 5.2%
Market Value (2033) US$ 6,520 million
Growth Factor Surging prevalence of chronic wounds
Opportunity Growing awareness about advanced wound treatment
Key Trends Rising preference of cost-effective treatment

Regional Analysis

Countries Market Share (2022)
United States 28.8%
Germany 6.3%
Japan 4.2%

North America To Dominate The Therapeutic Apheresis Industry

North America accounted for the leading share, i.e. 32.6% market share in 2022. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.

Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anemia, and neonatal cardiac lupus, support the growth of the market in this region.

Europe Likely To Portray A Promising Market For Therapeutic Apheresis

In 2022, Europe accounted for 29.8% market share in the global market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.

This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and a growing number of organ donors also is supporting the growth of the market in this region.

The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety, and an increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis sector.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-up Ecosystem In The Therapeutic Apheresis Industry

In June 2022, BioCaptiva raised nearly US$ 2.6 million in the latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, who joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.

Key Players Benchmarking The Therapeutic Apheresis Industry

The market has an oligopolistic structure and is characterized by frequent mergers and acquisitions. Industry companies frequently employ new product development and strategic partnerships as sustainability strategies.

  • Terumo BCT (US) and UniCAR-Therapy Bio-Medicine Technologies Co. cooperated in October 2019. (China). By establishing a new Shanghai Center of Excellence, this alliance aims to advance CAR T-cell therapy. This advancement also enabled Terumo to expand the scope of its apheresis and leukapheresis applications.
  • Fresenius Kabi invested EUR 30 million in the Dominican Republic to construct an apheresis and transfusion disposables facility in January 2020.

Key Players

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Terumo Bct
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Key Segments

By Procedure Types:

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology:

  • Centrifugation
  • Membrane filtration

By Application:

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Blood banks
  • Specialty clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the Therapeutic Apheresis Market CAGR for 2033?

The Therapeutic Apheresis Market CAGR for 2033 is 5.2%.

How Big Will the Therapeutic Apheresis Market be by 2033?

The market is estimated to reach US$ 5,264.4 million by 2033.

Who are the Key Therapeutic Apheresis Market Players?

Key market players in the Therapeutic Apheresis Market are Terumo BCT, Inc., Fresenius SE & Co. KGaA, and Haemonetics Corporation.

What is the Current Market Valuation of the Therapeutic Apheresis Market?

The market is estimated to secure a valuation of US$ 2,717.9 million in 2023.

What are the Current Trends in the Therapeutic Apheresis Market?

The market for apheresis is being driven by an increase in chronic disorders. Personal apheresis is expanding with new technology and home use. Patient security is a top priority.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Types

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Procedure Types, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure Types, 2023 to 2033

        5.3.1. Therapeutic Plasma Exchange (TPE)

        5.3.2. Red Blood Cell Exchange (RBCX)

        5.3.3. Cellular Depletions

    5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Procedure Types, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        6.3.1. Centrifugation

        6.3.2. Membrane filtration

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        7.3.1. Hematology

        7.3.2. Neurology

        7.3.3. Nephrology

        7.3.4. Rheumatology

        7.3.5. Oncology

        7.3.6. Others

    7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Hospitals

        8.3.2. Blood Banks

        8.3.3. Specialty Clinics

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Procedure Types

        10.2.3. By Technology

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Procedure Types

        10.3.3. By Technology

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Procedure Types

        11.2.3. By Technology

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Procedure Types

        11.3.3. By Technology

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Procedure Types

        12.2.3. By Technology

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Procedure Types

        12.3.3. By Technology

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Procedure Types

        13.2.3. By Technology

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Procedure Types

        13.3.3. By Technology

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Procedure Types

        14.2.3. By Technology

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Procedure Types

        14.3.3. By Technology

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Procedure Types

        15.2.3. By Technology

        15.2.4. By Application

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Procedure Types

        15.3.3. By Technology

        15.3.4. By Application

        15.3.5. By End User

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Procedure Types

        16.2.3. By Technology

        16.2.4. By Application

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Procedure Types

        16.3.3. By Technology

        16.3.4. By Application

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Procedure Types

            17.1.2.2. By Technology

            17.1.2.3. By Application

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Procedure Types

            17.2.2.2. By Technology

            17.2.2.3. By Application

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Procedure Types

            17.3.2.2. By Technology

            17.3.2.3. By Application

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Procedure Types

            17.4.2.2. By Technology

            17.4.2.3. By Application

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Procedure Types

            17.5.2.2. By Technology

            17.5.2.3. By Application

            17.5.2.4. By End User

    17.6. UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Procedure Types

            17.6.2.2. By Technology

            17.6.2.3. By Application

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Procedure Types

            17.7.2.2. By Technology

            17.7.2.3. By Application

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Procedure Types

            17.8.2.2. By Technology

            17.8.2.3. By Application

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Procedure Types

            17.9.2.2. By Technology

            17.9.2.3. By Application

            17.9.2.4. By End User

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Procedure Types

            17.10.2.2. By Technology

            17.10.2.3. By Application

            17.10.2.4. By End User

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Procedure Types

            17.11.2.2. By Technology

            17.11.2.3. By Application

            17.11.2.4. By End User

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Procedure Types

            17.12.2.2. By Technology

            17.12.2.3. By Application

            17.12.2.4. By End User

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Procedure Types

            17.13.2.2. By Technology

            17.13.2.3. By Application

            17.13.2.4. By End User

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Procedure Types

            17.14.2.2. By Technology

            17.14.2.3. By Application

            17.14.2.4. By End User

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Procedure Types

            17.15.2.2. By Technology

            17.15.2.3. By Application

            17.15.2.4. By End User

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Procedure Types

            17.16.2.2. By Technology

            17.16.2.3. By Application

            17.16.2.4. By End User

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Procedure Types

            17.17.2.2. By Technology

            17.17.2.3. By Application

            17.17.2.4. By End User

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Procedure Types

            17.18.2.2. By Technology

            17.18.2.3. By Application

            17.18.2.4. By End User

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Procedure Types

            17.19.2.2. By Technology

            17.19.2.3. By Application

            17.19.2.4. By End User

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Procedure Types

            17.20.2.2. By Technology

            17.20.2.3. By Application

            17.20.2.4. By End User

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Procedure Types

            17.21.2.2. By Technology

            17.21.2.3. By Application

            17.21.2.4. By End User

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Procedure Types

            17.22.2.2. By Technology

            17.22.2.3. By Application

            17.22.2.4. By End User

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Procedure Types

            17.23.2.2. By Technology

            17.23.2.3. By Application

            17.23.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Procedure Types

        18.3.3. By Technology

        18.3.4. By Application

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Asahi Kasei Medical Co.

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Haemonetics Corporation

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Miltenyi Biotec

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Cerus Corporation

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Terumo BCT Inc.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Fresenius Kabi USA

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Terumo Bct

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. B. Braun Melsungen AG

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Nikkiso Co. Ltd.

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Medica S.p.A.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

        19.1.11. Baxter Healthcare Corporation

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

        19.1.12. Kawasumi Laboratories Inc.

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

        19.1.13. Therakos Incorporation

            19.1.13.1. Overview

            19.1.13.2. Product Portfolio

            19.1.13.3. Profitability by Market Segments

            19.1.13.4. Sales Footprint

            19.1.13.5. Strategy Overview

                19.1.13.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Therapeutic Nuclear Medicine Market

March 2022

REP-GB-2930

March 2024

324 pages

Healthcare

Therapeutic Respiratory Devices Market

March 2022

REP-GB-14374

February 2023

345 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Therapeutic Apheresis Market